Literature DB >> 18755516

Animal models of anxiety: do I need multiple tests?

André Ramos1.   

Abstract

The combination of cutting-edge molecular technology and high-throughput phenotyping tools will not bring the expected contribution to the pre-clinical study of anxiety if not paralleled by an increase in our capacity to interpret behavioral data. Here, previous views about the multidimensional nature of emotional behaviors will be expanded and the psychological meaning and behavioral overlaps of widely used anxiety tests such as the open field, elevated plus maze and light-dark box will be discussed. It is proposed here that short-term, intra-individual variations in emotionality, although normally overlooked, constitute an important factor in the study of anxiety and can lead to unreliable estimates of the similarities between tests. The physical integration of different current tests in one single apparatus, in such a way that the emotional status of an animal becomes assessable through a series of distinct tasks, could contribute to increase reliability, rapidity and comprehensiveness in behavioral testing.

Entities:  

Mesh:

Year:  2008        PMID: 18755516     DOI: 10.1016/j.tips.2008.07.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  132 in total

1.  Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests.

Authors:  Leanne M Fraser; Richard E Brown; Ahmed Hussin; Mara Fontana; Ashley Whittaker; Timothy P O'Leary; Lauren Lederle; Andrew Holmes; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2010-05-08       Impact factor: 4.530

2.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

3.  The influence of sex and estrous cycle on QTL for emotionality and ethanol consumption.

Authors:  Geison S Izídio; Letícia C Oliveira; Lígia F G Oliveira; Elayne Pereira; Thaize D Wehrmeister; André Ramos
Journal:  Mamm Genome       Date:  2011-04-24       Impact factor: 2.957

Review 4.  Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.

Authors:  Natale R Sciolino; Philip V Holmes
Journal:  Neurosci Biobehav Rev       Date:  2012-07-05       Impact factor: 8.989

5.  Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference.

Authors:  Jeffrey S Smith; Abigail G Schindler; Emma Martinelli; Richard M Gustin; Michael R Bruchas; Charles Chavkin
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

6.  Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.

Authors:  Sergio D Iñiguez; Brandon L Warren; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

7.  Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice.

Authors:  C Del Boca; P E Lutz; J Le Merrer; P Koebel; B L Kieffer
Journal:  Neuroscience       Date:  2012-05-18       Impact factor: 3.590

Review 8.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

9.  Effect of ER-beta gene disruption on estrogenic regulation of anxiety in female mice.

Authors:  Kazuya Tomihara; Tomoko Soga; Masayoshi Nomura; Kenneth S Korach; Jan-Ake Gustafsson; Donald W Pfaff; Sonoko Ogawa
Journal:  Physiol Behav       Date:  2008-10-29

Review 10.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.